Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,797 | 204 | 98.1% |
| Education | $73.40 | 2 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $755.01 | 40 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $395.77 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $356.47 | 18 | $0 (2024) |
| Celgene Corporation | $246.15 | 19 | $0 (2019) |
| PFIZER INC. | $244.25 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $219.77 | 11 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $200.55 | 6 | $0 (2024) |
| Lilly USA, LLC | $181.14 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $153.71 | 10 | $0 (2024) |
| Journey Medical Corporation | $125.95 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,389 | 66 | ABBVIE INC. ($485.40) |
| 2023 | $923.21 | 44 | E.R. Squibb & Sons, L.L.C. ($208.06) |
| 2022 | $257.33 | 13 | ABBVIE INC. ($48.86) |
| 2020 | $98.58 | 5 | VYNE Pharmaceuticals Inc. ($27.29) |
| 2019 | $437.47 | 29 | Regeneron Healthcare Solutions, Inc. ($84.78) |
| 2018 | $365.64 | 25 | Celgene Corporation ($70.61) |
| 2017 | $399.58 | 24 | Regeneron Healthcare Solutions, Inc. ($127.50) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.80 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.46 | General |
| Category: Immunology | ||||||
| 10/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: DERMATOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: DERMATOLOGY | ||||||
| 08/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: DERMATOLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immunology | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: DERMATOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,918 | 7,512 | $1.4M | $289,258 |
| 2022 | 24 | 3,750 | 7,111 | $1.0M | $270,510 |
| 2021 | 26 | 3,842 | 7,412 | $831,341 | $292,729 |
| 2020 | 24 | 3,580 | 6,707 | $739,323 | $239,629 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 766 | 1,009 | $259,612 | $54,181 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 457 | $166,747 | $35,580 | 21.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 433 | 547 | $156,268 | $32,772 | 21.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 681 | 933 | $176,914 | $30,452 | 17.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 253 | 296 | $94,280 | $20,955 | 22.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 64 | 69 | $60,107 | $15,134 | 25.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 546 | 3,146 | $58,565 | $14,573 | 24.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 107 | 153 | $63,850 | $12,305 | 19.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 64 | 92 | $46,662 | $9,810 | 21.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 48 | 67 | $32,318 | $7,757 | 24.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 129 | 204 | $28,768 | $7,577 | 26.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 33 | 33 | $29,142 | $7,510 | 25.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $18,412 | $4,812 | 26.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 48 | 50 | $35,234 | $4,604 | 13.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $21,190 | $4,003 | 18.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 36 | 37 | $27,786 | $3,736 | 13.4% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $13,393 | $3,500 | 26.1% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 24 | 26 | $12,399 | $2,782 | 22.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 72 | $11,587 | $2,555 | 22.1% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 24 | 24 | $17,348 | $2,285 | 13.2% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 18 | $9,599 | $2,275 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $10,808 | $2,242 | 20.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 17 | 18 | $14,520 | $1,897 | 13.1% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 11 | 11 | $8,193 | $1,887 | 23.0% |
| 69100 | Biopsy of ear | Office | 2023 | 39 | 42 | $11,471 | $1,817 | 15.8% |
About Dr. Bradley Soder, MD
Dr. Bradley Soder, MD is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740219872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Soder, MD has received a total of $3,870 in payments from pharmaceutical and medical device companies, with $1,389 received in 2024. These payments were reported across 206 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,797).
As a Medicare-enrolled provider, Soder has provided services to 15,090 Medicare beneficiaries, totaling 28,742 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 07/01/2006
- Last Updated 07/12/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1740219872
Products in Payments
- RINVOQ (Biological) $437.45
- Sotyktu (Drug) $352.43
- DUPIXENT (Biological) $313.56
- SKYRIZI (Biological) $261.23
- EUCRISA (Drug) $244.25
- TALTZ (Drug) $181.14
- DUPIXENT DUPILUMAB INJECTION (Biological) $151.13
- ILUMYA (Biological) $138.59
- TREMFYA (Drug) $137.28
- VTAMA (Drug) $120.60
- ADBRY (Biological) $92.18
- COSENTYX (Biological) $82.23
- STELARA (Biological) $66.64
- Erivedge (Biological) $63.35
- LIBTAYO (Biological) $47.82
- RHOFADE (Drug) $40.54
- COSENTYX (Drug) $39.09
- Seysara (Drug) $35.85
- Humira (Biological) $34.83
- ILUMYA (tildrakizumab-asmn) injection (Biological) $34.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506